Search

KR-102963440-B1 - A functional composition that eliminates nitrosamines by eliminating toxic substances in the human body caused by smoking, thereby relieving respiratory diseases, inflammation and toxins in the lungs

KR102963440B1KR 102963440 B1KR102963440 B1KR 102963440B1KR-102963440-B1

Abstract

The present invention provides a functional composition for eliminating toxic substances generated by smoking in the human body, comprising dextrin, *Gomborbaechi* extract powder, vitamin C, *Cassia obtusifolia* extract powder, licorice concentrate powder, ginger extract powder, *Hwanggi* extract powder, *Platycodon grandiflorus* extract powder, propolis extract powder, Chlorella powder, turmeric extract powder, *Schisandra chinensis* extract powder, vitamin B1 hydrochloride, and vitamin B6 hydrochloride. The functional composition according to the present invention has the effect of eliminating nitrosamines by relieving respiratory diseases, inflammation of the lungs, and toxins through the elimination of toxic substances generated by smoking in the human body.

Inventors

  • 이성탄

Dates

Publication Date
20260511
Application Date
20250828

Claims (6)

  1. A step of soaking soybeans and kelp in purified water; a step of mixing 38-42 parts by weight of a mixture of soaked soybeans and kelp in a weight ratio of 4:1 with 58-62 parts by weight of purified water, and boiling at a temperature of 88-92℃ for 2-4 hours; a step of, after boiling, placing the mixture into a grinding device, grinding it, and filtering to remove solids and obtain a filtrate; a step of adding 0.8-1.2 parts by weight of Lactobacillus plantarum to 100 parts by weight of the filtrate, and fermenting at a temperature of 33-37℃ for 22-26 hours; a step of, after fermentation, adding 0.3-0.5 parts by weight of a complex enzyme mixture of exopeptidase and endoprotease in a weight ratio of 1:1, and enzymatically treating at a temperature of 43-47℃ for 5-7 hours. A step of preparing a nutrient supply solution comprising: a step of heating to a temperature of 88-92℃ and cooling to a temperature of 18-22℃ after enzyme treatment; and a step of preparing a re-filtered solution by re-filtering after cooling, mixing 3-7 parts by weight of calcium oxide, 3-7 parts by weight of erythritol, 1-5 parts by weight of vitamin B, 1-5 parts by weight of vitamin C, and 1-5 parts by weight of vitamin D with respect to 100 parts by weight of the re-filtered solution, and heating to a temperature of 53-57℃ to dissolve. A step of mixing 48-52 parts by weight of a complex obtained by mixing *Gondalbi* stems, *Sambaeckcho* roots, and *Cloud Mushroom* in a weight ratio of 1:1:1 with 48-52 parts by weight of the nutrient supply solution, and aging at a temperature of 58-62℃ for 2-4 days; a step of obtaining an aged product by filtration after aging, mixing 48-52 parts by weight of the obtained aged product with 48-52 parts by weight of purified water, adding 0.8-1.2 parts by weight of a *Monascus pilosus* strain, and fermenting at a temperature of 33-37℃; a step of obtaining a fermented product by filtration after fermentation, mixing 8-12 parts by weight of the obtained fermented product with 43-47 parts by weight of ethanol and 43-47 parts by weight of chloroform, and extracting by ultrasonic irradiation at a temperature of 78-82℃ for 8-10 hours; A step of preparing a complex extract powder comprising: a step of filtering the extract through filter paper after extraction, followed by vacuum concentration and freeze-drying the filtrate; and A step of mixing 8-12 parts by weight of the above-mentioned complex extract powder, 28-32 parts by weight of dextrin, 12-16 parts by weight of *Gomborbaechu* extract powder, 9-13 parts by weight of vitamin C, 8-12 parts by weight of *Gyeolmyeongja* extract powder, 8-12 parts by weight of licorice concentrate powder, 7-9 parts by weight of ginger extract powder, 7-9 parts by weight of *Hwanggi* extract powder, 4-6 parts by weight of *Platycodon grandiflorus* extract powder, 0.8-1.2 parts by weight of propolis extract powder, 0.8-1.2 parts by weight of Chlorella raw powder, 0.8-1.2 parts by weight of turmeric extract powder, 0.8-1.2 parts by weight of *Omija* extract powder, 0.08-0.12 parts by weight of vitamin B1 hydrochloride, and 0.08-0.12 parts by weight of vitamin B6 hydrochloride; comprising nitrosamines among toxic substances inducing toxicity in the human body generated through smoking Method for preparing a functional food composition that inhibits formation and promotes nicotine metabolism.
  2. delete
  3. delete
  4. delete
  5. delete
  6. delete

Description

A functional composition that eliminates nitrosamines by eliminating toxic substances in the human body caused by smoking, thereby relieving respiratory diseases, inflammation, and toxins in the lungs The present invention relates to a functional composition that eliminates nitrosamines by resolving respiratory diseases, lung inflammation, and toxins through the expulsion of toxic substances generated within the human body through smoking. With the advancement of modern civilization, many affordable and nutrient-rich foods have been developed. However, while mass production offers positive benefits, such as the ease of obtaining high nutrition, it has also resulted in an increased consumption of foods containing high concentrations of various toxic substances. Consequently, beyond the basic necessities of diet, modern people have come to desire natural foods that are free from refinements or additives, and methods have been established to regulate the consumption of general foods to some extent. Since foods are not addictive, such harmful effects can be mitigated through the control of intake, and various alternatives have been devised to address this. However, among the many ingested substances that harm human health, none cause as much damage as tobacco while being controllable in principle. This is due to its strong addictive nature, which prevents people from reducing their smoking despite knowing the harmful effects. Tobacco accounts for the largest proportion of direct causes of death among modern people, even setting aside related diseases. As is well known, smoking is a cause of various diseases, and approximately 4,000 types of chemical components are produced and inhaled into the human body during smoking. Tobacco smoke can be divided into gaseous and particulate components. Major gaseous components harmful to the human body include carbon monoxide, carbon dioxide, nitrosamines, nitrogen compounds, hydrogen cyanide, and ammonia, while major harmful particulate substances include nicotine, tar, phenol, poronium-210 (radioactive material), arsenic, cresol, cyanide, benzopyrene, and acrolein. When smoking, approximately 50 mg of cigarette smoke is inhaled into the human body, consisting of 18 mg of particulate matter and 32 mg of gaseous matter (5% CO gas). Among the toxic substances in the inhaled cigarette, almost all of the carbon monoxide is absorbed, 90% of the nicotine reaches the brain, and about 70% of the tar accumulates in the airways, causing toxicity. The substances exhibiting the greatest toxicity are nicotine and tar. Nicotine is a colorless, highly addictive alkaloid. Symptoms such as vomiting, dizziness, and headaches experienced when first smoking or smoking excessively are caused by nicotine; it takes approximately 7 seconds for nicotine in inhaled cigarette smoke to reach the brain. This substance is not destroyed during the smoking process, and 0.1–0.2 mg of nicotine (2 mg per cigarette) is absorbed into the body with every puff of smoke. Nicotine is highly toxic; absorbing 60 mg into the bloodstream at once will result in death for most people. The lethal dose for adults is 1 mg of nicotine per kilogram of body weight. Nicotine causes vasoconstriction of capillaries and peripheral blood vessels, increases blood pressure (an increase of 20–30 mmHg per cigarette), accelerates heart rate, stimulates nerves, increases gastric acid secretion, alters serum lipids (increase in LDL, decrease in HDL), increases platelet aggregation, and damages blood vessel walls, thereby promoting atherosclerosis. Various embodiments are described in more detail below. The embodiments described herein may be modified in various ways. Specific embodiments may be described in detail in the detailed description. However, the specific embodiments disclosed are intended only to facilitate understanding of various embodiments. Accordingly, the technical concept is not limited by the specific embodiments disclosed, and it should be understood that it includes all equivalents or substitutions that fall within the spirit and scope of the invention. Terms including ordinal numbers, such as first, second, first, second, etc., may be used to describe various components, but these components are not limited by the aforementioned terms. The aforementioned terms are used solely for the purpose of distinguishing one component from another. In this specification, terms such as "comprising" or "having" are intended to indicate the existence of the features, numbers, steps, actions, components, parts, or combinations thereof described in the specification, and should be understood as not precluding the existence or addition of one or more other features, numbers, steps, actions, components, parts, or combinations thereof. When a component is described as being "connected" or "connected" to another component, it should be understood that it may be directly connected to or connected to that other component, or that there may